STOCK TITAN

Coherus BioSciences Announces New Employment Inducement Grants

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
Coherus BioSciences, Inc. (Nasdaq: CHRS) granted options to purchase 192,000 shares of common stock to five newly hired employees. One executive was granted an option to purchase 150,000 shares, and four non-officer employees were granted options to purchase 42,000 shares. The options were granted under the 2016 Employment Commencement Incentive Plan approved by the Company's board of directors.
Positive
  • None.
Negative
  • None.

REDWOOD CITY, Calif., Dec. 22, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective December 20, 2023, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 192,000 shares of the common stock of the Company to five newly hired employees with a per share exercise price of $1.94, the closing trading price on the grant date. One Executive Vice President level executive was granted an option to purchase 150,000 shares; and four additional non-officer employees were granted options to purchase an aggregate of 42,000 shares.

The stock options were granted pursuant to the Coherus BioSciences, Inc. 2016 Employment Commencement Incentive Plan, which was approved by the Company’s board of directors in June 2016 under Rule 5635(c)(4) of the Nasdaq Global Select Market for equity grants to induce new employees to enter into employment with the Company.

Coherus BioSciences Contact Information:

IR Contact
Jami Taylor, Head of Investor Relations
Coherus BioSciences, Inc.
IR@coherus.com


FAQ

What did Coherus BioSciences announce on December 22, 2023?

Coherus BioSciences, Inc. announced the granting of stock options to newly hired employees, including an executive and four non-officer employees.

How many shares of common stock were included in the options granted?

A total of 192,000 shares of common stock were included in the options granted.

Under which plan were the stock options granted?

The stock options were granted under the Coherus BioSciences, Inc. 2016 Employment Commencement Incentive Plan.

What is the ticker symbol for Coherus BioSciences?

The ticker symbol for Coherus BioSciences is CHRS and it is listed on Nasdaq.

Coherus BioSciences, Inc.

NASDAQ:CHRS

CHRS Rankings

CHRS Latest News

CHRS Stock Data

124.43M
110.58M
1.39%
70.1%
27.35%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
REDWOOD CITY